计算评估心力衰竭和连续流动的左心室辅助装置在贫血中的支持
1School of Engineering, Ulster University, Belfast, UK.
概括
贫血显著增加了心力衰竭患者的脑血流与连续流动左心室辅助装置 (CF-LVAD). 然而,缺铁会导致心室扩张,这突显了对心脏功能和血液流动的明显影响.
科学领域:
- 心血管生理学心血管生理学
- 生物医学工程 生物医学工程
- 计算生物学 计算生物学
背景情况:
- 贫血在末期心力衰竭患者中很普遍,需要持续流动的左心室辅助装置 (CF-LVAD) 支持.
- 这种人群的贫血与不良结果有关,包括心力衰竭再入院.
研究的目的:
- 为了研究贫血对心脏功能和脑血流的血液动力学影响,心脏衰竭患者CF-LVAD支持.
- 利用计算模拟来建模这些效应.
主要方法:
- 开发了一个动态计算模型,模拟心脏功能,全身,肺和大脑循环,以及大脑自我调节.
- 该模型包含了CF-LVAD治疗的HeartMate 3模拟.
- 通过降低血红蛋白水平和改变心室体积参数来模拟贫血和铁缺乏症.
主要成果:
- 降低的血红蛋白水平 (贫血) 导致大脑血流率增加>50%,这是由于动脉O2含量降低.
- 贫血对动脉/心房压力和心室体积的影响很小.
- 在心力衰竭和CF-LVAD支持场景中,缺铁导致末端透气心室直径增加.
结论:
- 开发的数值模型准确地模拟了心力衰竭和CF-LVAD治疗期间贫血的血液动力学影响.
- 该模型与临床数据保持一致,可以成为评估CF-LVAD治疗的有价值工具.
- 贫血和缺铁对CF-LVAD患者产生明显的血液动力学影响.
更多相关视频
相关概念视频
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Heart Failure IV: Classification and Diagnostic Evaluation
19
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
19
Heart Failure II: Pathophysiology
14
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14
Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Heart Failure V: Medical Management
10
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
10


